Mutations in essential pathway components can cause persistent Smad3 linker phosphorylation, so highly phosphorylated Smad3L likely reduces pSmad3C’s sensitivity to growth inhibition in tumor cells (26, 202–204). This evidence concerns the gene SMAD3 and neoplasm.